31 Mar 2023
Assets93.89
Total Income80.19
EBITDA8.83
Profit After Tax5.08
NET Worth63.54
Reserves and Surplus59.40
Total Borrowing19.17
Open 30th Sep 2025 · Close 3rd Oct 2025 · Listing 8th Oct 2025
The shares listed at ₹91.00, a 44.44% move from the issue price. Sheel Biotech is a SME IPO with an issue size of ₹34.02 crore, proposed for listing on NSE SME. The offer opens on 30th Sep 2025 and closes on 3rd Oct 2025. The issue structure includes a fresh issue of ₹32.31 crore. The current listing schedule points to 8th Oct 2025.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | ₹252,000 |
| Object | Amount |
|---|---|
| Capital Expenditure Requirement | ₹9.12 Cr |
| Working Capital Requirement | ₹15.88 Cr |
| General Corporate Purposes | ₹4.77 Cr |
| Issue Expense | ₹4.25 Cr |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt / Equity | 0.21% |
| RoNW | 13.59% |
| PAT Margin | 10.45% |
| EBITDA Margin | 14.71% |
| Price to Book Value | 1.11 |
| Expense | Amount |
|---|---|
| Book Running Lead manager(s) fees including underwriting commission. | ₹2.00 Cr |
| Brokerage, selling commission and upload fees | ₹0.01 Cr |
| Registrars to the issue | ₹0.01 Cr |
| Legal Advisors | ₹0.02 Cr |
| Peer Review Auditor fees | ₹0.03 Cr |
| Printing, Advertising and marketing expenses | ₹0.06 Cr |
| Regulators including stock exchanges | ₹0.10 Cr |
| Others, if any (Market Maker fees, Selling and Distribution Expenses, Marketing Expenses and other misc. expenses) | ₹2.03 Cr |